These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35893231)

  • 1. Deciphering the Molecular Mechanism of Incurable Muscle Disease by a Novel Method for the Interpretation of miRNA Dysregulation.
    Israeli D; Vu Hong A; Corre G; Miagoux Q; Richard I
    Noncoding RNA; 2022 Jun; 8(4):. PubMed ID: 35893231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients.
    Jeanson-Leh L; Lameth J; Krimi S; Buisset J; Amor F; Le Guiner C; Barthélémy I; Servais L; Blot S; Voit T; Israeli D
    Am J Pathol; 2014 Nov; 184(11):2885-98. PubMed ID: 25194663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive serum miRNA profile in mouse models of striated muscular pathologies.
    Vignier N; Amor F; Fogel P; Duvallet A; Poupiot J; Charrier S; Arock M; Montus M; Nelson I; Richard I; Carrier L; Servais L; Voit T; Bonne G; Israeli D
    PLoS One; 2013; 8(2):e55281. PubMed ID: 23418438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing dysregulation secondary to skeletal muscle regeneration.
    Orengo JP; Ward AJ; Cooper TA
    Ann Neurol; 2011 Apr; 69(4):681-90. PubMed ID: 21400563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of hub genes, miRNAs and regulatory factors relevant for Duchenne muscular dystrophy by bioinformatics analysis.
    Xiu MX; Zeng B; Kuang BH
    Int J Neurosci; 2022 Mar; 132(3):296-305. PubMed ID: 32791870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community Structure Analysis of Gene Interaction Networks in Duchenne Muscular Dystrophy.
    Narayanan T; Subramaniam S
    PLoS One; 2013; 8(6):e67237. PubMed ID: 23840633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy.
    Catapano F; Scaglioni D; Maresh K; Ala P; Domingos J; Selby V; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Voit T; Verschuuren JJGM; Niks EH; Straub V; Morgan J; Muntoni F
    Epigenomics; 2020 Nov; 12(21):1899-1915. PubMed ID: 33215544
    [No Abstract]   [Full Text] [Related]  

  • 8. C-X-C motif chemokine ligand 12: a potential therapeutic target in Duchenne muscular dystrophy.
    Lai X; Chen J
    Bioengineered; 2021 Dec; 12(1):5428-5439. PubMed ID: 34424816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA and mRNA Expression Changes in Steroid Naïve and Steroid Treated DMD Patients.
    Liu DZ; Stamova B; Hu S; Ander BP; Jickling GC; Zhan X; Sharp FR; Wong B
    J Neuromuscul Dis; 2015 Sep; 2(4):387-396. PubMed ID: 27858746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.
    Chen W; Zhao W; Yang A; Xu A; Wang H; Cong M; Liu T; Wang P; You H
    Gene; 2017 Dec; 636():87-95. PubMed ID: 28919164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients.
    Capitanio D; Moriggi M; Torretta E; Barbacini P; De Palma S; Viganò A; Lochmüller H; Muntoni F; Ferlini A; Mora M; Gelfi C
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):547-563. PubMed ID: 31991054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.
    Srivastava NK; Yadav R; Mukherjee S; Pal L; Sinha N
    Magn Reson Imaging; 2017 May; 38():163-173. PubMed ID: 28069416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of Long Non-coding RNA-Associated Competing Endogenous RNA Network in Duchenne Muscular Dystrophy.
    Xu X; Hao Y; Xiong S; He Z
    Interdiscip Sci; 2020 Dec; 12(4):447-460. PubMed ID: 32876881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs and Duchenne muscular dystrophy.
    Perry MM; Muntoni F
    Epigenomics; 2016 Nov; 8(11):1527-1537. PubMed ID: 27603567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy.
    Hrach HC; Mangone M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNome profiling in Duchenne muscular dystrophy; identification of asymptomatic and manifesting female carriers.
    Mousa NO; Sayed AA; Fahmy N; Elzayat MG; Bakry U; Abdellatif A; Zahra WK; Osman A
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34472584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of miRNA-29, -23 and -21 in urine of Duchenne muscular dystrophy patients.
    Catapano F; Domingos J; Perry M; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Niks EH; Verschuuren JJ; Straub V; Voit T; Morgan J; Muntoni F
    Epigenomics; 2018 Jul; 10(7):875-889. PubMed ID: 29564913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization.
    Ghahramani Seno MM; Trollet C; Athanasopoulos T; Graham IR; Hu P; Dickson G
    BMC Genomics; 2010 Jun; 11():345. PubMed ID: 20515474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
    Hoffman EP
    Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.